"Designing Growth Strategies is in our DNA"
The U.S. medical imaging market size was worth USD 10.53 billion in 2023 and is projected to grow at a CAGR of 5.1% during the forecast period.
The rising incidence of chronic diseases, such as neurology, cardiovascular disorders, and cancer, among others, and the increasing number of advanced healthcare imaging modalities have led to high emphasis on early diagnosis among the U.S population.
Thus, the surge in the prevalence of these diseases is leading to an increasing number of diagnostic imaging procedures across the healthcare systems, further propelling the growth market. The COVID-19 pandemic impeded a negative impact on the market in 2020 due to the significant decline in patient visits to hospitals for disease diagnosis across the country.
Introduction of AI-enabled Imaging Systems by Key Players
The rise in the launch of advanced medical imaging systems by industry players is one of the significant factors propelling the adoption of these devices across health settings. The increasing presence of advanced artificial intelligence-enabled imaging systems for early diagnosis and disease treatment in the U.S. is the major factor contributing to the growing demand for medical imaging devices.
Thus, the rise in the introduction and demand for Artificial Intelligence (AI)-enabled equipment for diagnostic imaging across the country is driving the U.S. medical imaging market growth.
Rising Launch of Advanced Systems by Industry Players to Drive the Adoption of Imaging Systems
Several factors, such as the growing emphasis on early diagnosis of debilitating disorders and the rise in the aging population in the U.S. are projected to propel the need for imaging systems. Similarly, the introduction of new systems, such as compact ultrasound and molecular imaging devices by leading players, are some of the major elements simulating the market growth.
Thus, the surge in the launch of several new systems in medical imaging is expected to spur their demand, further propelling the growth of the U.S. market.
Request a Free sample to learn more about this report.
Product Recalls by Regulatory Agencies to Limit Market Growth
Recurrent product recalls of imaging equipment by federal agencies owing to increased system defects for safety and quality errors are one of the major factors expected to hamper the U.S. medical imaging market growth during the forecast period.
These factors, coupled with the rising presence of low-cost refurbished equipment, further restrict the adoption of innovative equipment in the U.S.
On the basis of type, the market is segmented into x-ray, magnetic resonance imaging, molecular imaging, computed tomography, and ultrasound.
The x-ray segment dominated the market in 2022, attributed to the increasing advancements of interventional x-ray devices by industry players, and the rise in the use of these systems, including C-arms, for image-guided surgeries nationwide.
Based on application, the market is segmented into orthopedics, cardiology, oncology, gynecology, neurology, and others.
The application segment was dominated by orthopedics in 2022. The higher share was attributable to the rising incidence rate of trauma and sports injuries among the population, further boosting the demand for medical imaging systems across healthcare settings.
Based on end user, the market is segmented into diagnostic imaging centers, specialty clinics, hospitals, and others.
The diagnostic imaging centers segment dominated the market in 2022, owing to the rise in the number of diagnostic imaging centers due to high demand among the U.S. population.
GE Healthcare, Koninklijke Philips N.V., and Siemens Healthcare GmbH are among the leading players operating in the imaging equipment market in 2022. The high emphasis of industry players on the introduction of technologically advanced and portable systems against traditional systems to aid in diagnostic imaging further propels the U.S. medical imaging market share.
Other key players, such as Shimadzu Corporation, Hitachi, Ltd., Samsung, Butterfly Inc., Analogic, and Hologic Inc., have also entered the U.S. market by introducing novel and technologically advanced devices. Moreover, rising initiatives of collaborations among key players to expand their existing product portfolio further drives their company growth.
An Infographic Representation of U.S. Medical Imaging Market
To get information on various segments, share your queries with us
The U.S. medical imaging market research report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, and leading applications of the product. Moreover, it offers insights into the market growth trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that contributed to the growth and advancement of the market in recent years.
ATTRIBUTE | DETAILS |
Study Period | 2019-2032 |
Base Year | 2023 |
Estimated Year | 2024 |
Forecast Period | 2024-2032 |
Historical Period | 2019-2022 |
Growth Rate | CAGR of 5.1% from 2024 to 2032 |
Unit | Value (USD Billion) |
Segmentation | By Type
|
By Application
| |
By End User
|
Fortune Business Insights says the market size was USD 10.53 billion in 2023.
Growing at a CAGR of 5.1%, the market will exhibit steady growth over the forecast period (2024-2032).
The X-ray segment is expected to be the leading segment in the market during the forecast period.
GE HealthCare, Koninklijke Philips N.V., and Siemens Healthcare GmbH are the major players in the U.S. market.
US +1 833 909 2966 ( Toll Free )